Alan vs SigTuple
In-depth comparison — valuation, funding, investors, founders & more
🇫🇷 France · Jean-Charles Samuelian
Valuation
$1.4B
Total Funding
$220M
500-1000 employees
🇮🇳 India · Rohit Kumar Pandey
Valuation
N/A
Total Funding
$20M
100-500 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Alan and SigTuple compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources. SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists.
Alan carries a known valuation of $1.4B, while SigTuple's valuation has not been publicly disclosed. On the funding side, Alan has raised $220M in total — $200M more than SigTuple's $20M.
SigTuple has 1 year more market experience, having been founded in 2015 compared to Alan's 2016 founding. In terms of growth stage, Alan is at Series D while SigTuple is at Series B — a meaningful difference for investors evaluating risk and upside.
Alan operates out of 🇫🇷 France while SigTuple is based in 🇮🇳 India, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Alan leads with a score of 83, reflecting stronger overall fundamentals across valuation, funding, and growth signals.
Metrics Comparison
| Metric | Alan | SigTuple |
|---|---|---|
💰Valuation | $1.4B | N/A |
📈Total Funding | $220MWINS | $20M |
📅Founded | 2016WINS | 2015 |
🚀Stage | Series D | Series B |
👥Employees | 500-1000 | 100-500 |
🌍Country | France | India |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 83WINS | 60 |
Key Differences
Funding gap: Alan has raised $200M more ($220M vs $20M)
Market experience: SigTuple has 1 year more (founded 2015 vs 2016)
Growth stage: Alan is at Series D vs SigTuple at Series B
Team size: Alan has 500-1000 employees vs SigTuple's 100-500
Market base: 🇫🇷 Alan (France) vs 🇮🇳 SigTuple (India)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Alan scores 83/100 vs SigTuple's 60/100
Which Should You Choose?
Use these signals to make the right call
Choose Alan if…
Top Pick- ✓Higher Awaira Score — 83/100 vs 60/100
- ✓More established by valuation ($1.4B)
- ✓Stronger investor backing — raised $220M
- ✓France-based for regional compliance or proximity
- ✓Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources
Choose SigTuple if…
- ✓More market experience — founded in 2015
- ✓India-based for regional compliance or proximity
- ✓SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists